论文部分内容阅读
目的:针对晚期非小细胞肺癌化疗患者进行双环醇片的肝损伤防治临床治疗研究,观察临床效果。方法:在本院收集82例确诊为晚期非小细胞肺癌患者资料,采取随机的方式将患者划分为两组,其中常规组患者采取常规药物干预41例,观察组患者采取双环醇片干预治疗41例。结束治疗后进行肝功能检验,观察临床治疗效果。结果:观察组患者肝损伤几率为7.3%,常规组患者肝损伤几率为36.6%,观察组临床疗效明显优于常规组,两组比较差异具有统计学意义(P<0.05)。结论:针对晚期非小细胞肺癌化疗患者采取双环醇片防治肝损伤的治疗方式具有良好的临床效果,能够降低患者出现的药物损伤几率,改善患者治疗中的不适感觉,避免患者出现不良治疗情绪,值得在临床治疗中推广。
OBJECTIVE: To study the clinical effects of bicyclol in the treatment of advanced non-small cell lung cancer (NSCLC) patients undergoing chemotherapy and to observe the clinical effect. Methods: 82 cases of patients with advanced non-small cell lung cancer were collected in our hospital. Patients were randomly divided into two groups. Among them, 41 cases were treated with conventional drugs in the routine group and 41 cases were treated with bicyclol tablets example. After the end of treatment of liver function tests to observe the effect of clinical treatment. Results: The incidence of liver injury was 7.3% in the observation group and 36.6% in the conventional group. The clinical efficacy of the observation group was significantly better than that of the conventional group. There was significant difference between the two groups (P <0.05). Conclusion: The treatment of liver injury in patients with advanced non-small cell lung cancer chemotherapy treated with bicyclic alcohol tablets has a good clinical effect, can reduce the probability of drug damage in patients, improve the discomfort in patients with treatment, to avoid patients with adverse treatment emotions, Worth to promote in clinical treatment.